* AtriCure Inc ATRC.OQ reported a quarterly adjusted loss
of 23
cents per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 34 cents per share.
* Revenue rose 25.4% to $93.49 million from a year ago;
analysts
expected $87.53 million.
* AtriCure Inc's reported EPS for the quarter was a loss
of 14
cents.
* The mean earnings estimate of analysts had fallen by
about 32.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* AtriCure Inc shares had risen by 8.9% this quarter and
gained 1.7% so far this year.
* The company reported a quarterly loss of $6.48 million.
* Wall Street's median 12-month price target for AtriCure
Inc is
$55.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
2 at 09:00 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.34 -0.23 Beat
Dec. 31 2022 -0.18 -0.09 Beat
Sep. 30 2022 -0.25 -0.27 Missed
Jun. 30 2022 -0.29 -0.32 Missed